inhibitors

Documents about inhibitors

• Chromone-based PDE2 inhibitors as potential prostate cancer therapeutics#363814Figshare
• Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors#848352ClinicalTrials.gov
• Catechols: A new class of carbonic anhydrase inhibitors#254338IRIS
• ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects#807202ClinicalTrials.gov
• Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke#208403ClinicalTrials.gov
• Combining VEGFR tyrosine kinase inhibitors and PD-1/PD-L1 inhibitors versus VEGFR tyrosine kinase inhibitors monotherapy in renal cell carcinoma: a target trial emulation#417388bioRxiv / medRxiv
• HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?#643943IBISS
• Anthraquinones as inhibitors of SOS RAS-GEF activity#294468Gestión del Repositorio Documental de la Universidad de Salamanca
• Glycoprotein IIb / IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre‐treated with newer P2Y12 inhibitors#670167HAL (France)
• The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins#842097ClinicalTrials.gov
• Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors#866308ClinicalTrials.gov
• Recent advances in HER2-targeted inhibitors for cancer therapy#478493Europe PMC
• Safety and Pharmacokinetics of JAK/ROCK Inhibitor in Healthy Volunteers#855506ClinicalTrials.gov
• SGLT2-inhibitors on PC-AKI#875415ClinicalTrials.gov
• Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia#839649ClinicalTrials.gov
• Management of Angiotensin Inhibitors During the Perioperative Period#859714ClinicalTrials.gov
• PCSK9 inhibitors patterns of use in France from nationwide repeated cross-sectional and cohort studies#15491HAL (France)
• PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer#256901ClinicalTrials.gov
• Role of prothrombin complex concentrates in reversal of direct oral anticoagulant effects#348457Recep Tayyip Erdoğan University Institutional Repository
• Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer#812371ClinicalTrials.gov
• The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies#633718ClinicalTrials.gov
• Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients#845417ClinicalTrials.gov
• A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations#862823ClinicalTrials.gov
• Aromatase inhibitors induce pain‐like musculoskeletal symptoms in mice: behavioural, pharmacological and pathophysiological characterization#624597HAL (France)
• In Vivo Effects of Amylase Trypsin Inhibitors#846699ClinicalTrials.gov
• Effect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells#847868ClinicalTrials.gov
• Pharmacogenetics of Ace Inhibitor-Associated Angioedema#854932ClinicalTrials.gov
• Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets#875769ClinicalTrials.gov
• A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments#844465ClinicalTrials.gov
• SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study#353427ClinicalTrials.gov
• Unvealing newly discovered small molecules as ACE2-spike inhibitors against SARS-CoV-2.#644266IRIS
• Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis#685930ScholarBank@NUS
• Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients#854153ClinicalTrials.gov
• Angiogenesis Inhibitors and Hypertension: Clinical Aspects#172430ClinicalTrials.gov
• Synthesis of Polyisoxazolinies as Potential Corrosion Inhibitors#284595KFUPM ePrints
• Phosphodiesterase Inhibitors in Glaucoma Study (PhiGS)#329389ClinicalTrials.gov
• The peripheral immune landscape of human breast cancer#642697Europe PMC
• Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors#837275ClinicalTrials.gov
• A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery#843703ClinicalTrials.gov
• Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes#853941ClinicalTrials.gov
• Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer#860502ClinicalTrials.gov
• A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)#872184ClinicalTrials.gov
• Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer#175738HAL (France)
• Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.#244232NCBI PubMed Central
• SGLT2 Inhibitors in Hypertrophic Cardiomyopathy: Emerging Evidence and Putative Mechanisms#480434HAL (France)
• Targeted therapy in pancreatic ductal adenocarcinoma: current advances and challenges#667087ULRR
• A Study of Elranatamab for Inhibitor Eradication in Patients With Hemophilia A#803382ClinicalTrials.gov
• Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy#805519ClinicalTrials.gov
• JAKPOT (JAK Inhibitors and Predictors of Outcome in RheumaToid Arthritis)#811837ClinicalTrials.gov
• Therapy code list - ACE inhibitors#206177LSHTM Data Compass